Navigation Links
Cyclacel Pharmaceuticals to Present Preclinical Data on,Sapacitabine and Seliciclib at AACR

t product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, the risk that Cyclacel will not obtain approval to market its products, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. These factors and others are more fully discussed under "Risk Factors" in the registration statement on Forms S-3 (File No. 333-134945) and S-4 (File No. 333-131225) and in the other reports of Cyclacel filed with the SEC.

Contact

For Cyclacel:
For Investors:
Tara Spiess / Andrea Romstad, 914-921-5900
TS Communications Group, LLC
or
For Media:
Robert Gottlieb/Kate Weiss, 617-577-8110
Feinstein Kean Healthcare


'"/>




Page: 1 2 3 4

Related medicine technology :

1. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
2. Cyclacel Pharmaceuticals to Report Sapacitabine Phase I Study Results at the American Society of Clinical Oncology Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
(Date:5/6/2015)... Johnson & Johnson (NYSE: JNJ ) ... party to review requests made to the Janssen Pharmaceutical ... compassionate use of its investigational medicines. This new approach ... single Janssen investigational medicine and, if successful, will become ... Johnson & Johnson. In keeping with the ...
(Date:5/6/2015)... 6, 2015  Zimmer Holdings, Inc. (NYSE and SIX: ZMH), ... will be presenting at the Bank of America Merrill Lynch ... Las Vegas, Nevada on Wednesday, May ... live webcast of the presentation can be accessed via Zimmer,s ... be archived for replay following the conference. About ...
(Date:5/6/2015)... NEW YORK , May 6, 2015  The ... ("GEVA" or the "Company") by Alexion Pharmaceuticals, Inc. ("Alexion") ... action, shareholder rights law firm, for possible breaches of ... Board of Directors of GEVA for agreeing to sell ... Company announced a definitive agreement for Alexion to acquire ...
Breaking Medicine Technology:Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 2Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 3Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 4Johnson & Johnson Announces NYU School of Medicine Partnership To Evaluate Compassionate Use of Investigational Medicines 5WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2
... Neuralstem, Inc. (NYSE Amex: CUR ) announced ... trial to test its neuroregenerative small molecule drug, NSI-189, in ... the drug in healthy volunteers for safety and tolerability. Phase ... will test the safety and tolerability of NSI-189 in depressed ...
... Since its initial inception, Echosens has ... and strengthen its product range with the recent introduction ... Equipped with a new and more ergonomic tactile interface, ... latest FibroScan ® provides a reliable, accurate and ...
Cached Medicine Technology:Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial 2Neuralstem Completes Phase Ia in Neuroregenerative Small Molecule Drug, NSI-189, Major Depressive Disorder Trial 3Echosens: Launch of the FibroScan®502 Touch 2
(Date:5/6/2015)... May 07, 2015 A poker run to raise ... May 30. , The poker run will start at the United ... p.m. , During the poker run, participants will visit checkpoints, ... the best poker hand at the end of the run. The ... 172 miles to York Offsides Tavern, Fairmont American Legion, Hastings DAV ...
(Date:5/6/2015)... New Standards for Excipient GMPs:, ... May 27, 2015 — 1:30 p.m. – 3:00 ... contain 70-90% excipients, which serve as taste-maskers, glidants, ... that facilitate the manufacturing process and improve chemical ... with a regulatory focus on preventing counterfeits and ...
(Date:5/6/2015)... Device Patent Law Changes:, Six Key Areas of ... 12:30 p.m. EDT, http://www.fdanews.com/DevicePatentLaw , Every year, medical ... claims that waste their time. , It doesn't have ... prevented if devicemakers better understand the trouble spots to watch ... to patent laws from all around the world. , Why ...
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini clothing store ... Southern China, it is becoming apparent to people all over ... This is especially true for High Net Worth Individuals and ... the property they own, the schools their children attend or ... families and companies that are at higher risk than most ...
(Date:5/6/2015)... NASHVILLE, Tenn. (PRWEB) May 06, 2015 ... is open for the Game Changers Summit 2015 ... ) conference hosted by United Methodist Communications. Join the ... in Nashville when technology and communication leaders from around ... strategy to aid social good throughout the developing world. ...
Breaking Medicine News(10 mins):Health News:Updated Contacts: Poker Run Fundraiser to Benefit National Veterans Golden Age Games 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 2Health News:FDAnews Announces — Device Patent Law Changes: Six Key Areas of Concern Webinar, May 27, 2015 3Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 3
... has ,Lifeguard(TM) ... Protection, ... new line of all natural 100% juice superfood smoothies that,combine the ... Protection," a fortification package of,essential vitamins, nutrients, amino acids, electrolytes and ...
... Meets MD,s Treatment Need, BETHESDA, Md., May 12 ... U.S. and abroad, has been found to,reduce the spikes of ... 3 human clinical trial, Spherix (Nasdaq: SPEX ) is ... of,diabetes. While the Phase 3 trial is ongoing, Spherix has ...
... FORT MYERS, Fla., May 12 Dawning ... small footprint interface device in,the new JavaLin/PDI ... fifth,generation of intelligent clinical interfaces from Dawning ... capabilities primarily aimed at the,connection of clinical ...
... -- Are the health needs of women adequately addressed ... the May issue of Mayo Clinic Proceedings, a team ... question. , The traditional model of medical research was ... results of research on white male participants could be ...
... National Women,s,Health Week kicks off this week and ... Dr. Calvin Johnson. This year,s theme is,"It,s Your Time: ... caregivers for their spouses, children and parents,and many times ... Johnson.,"However, research shows that when women take care of ...
... Level, AURORA, Colo., May 12 With health ... world, the demand for nurses with,advanced experience and education ... in their field, American Sentinel,University is accepting students for ... Nursing program., For many nurses looking to advance ...
Cached Medicine News:Health News:New Sun Shower(TM) Superfood Smoothies 2Health News:New Sun Shower(TM) Superfood Smoothies 3Health News:Market Research Shows Spherix's Naturlose(R) Readily Accepted by Diabetes Patients 2Health News:Market Research Shows Spherix's Naturlose(R) Readily Accepted by Diabetes Patients 3Health News:Dawning Technologies, Inc. Releases JavaLin/PDI Portable Device Interface 2Health News:Medical research should include more women participants and examine the role of gender in disease 2Health News:Medical research should include more women participants and examine the role of gender in disease 3Health News:American Sentinel University Accepting Enrollment in Online RN to BS in Nursing 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: